Related Experiment Video
Updated: Jun 12, 2026
09:57
Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Published on: September 20, 2024
Recent concepts on cyclic vomiting syndrome in children
1Department of Pediatrics, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea.
Journal of Neurogastroenterology and Motility
|June 11, 2010
Summary
Cyclic vomiting syndrome (CVS) requires careful diagnosis and management. Early intervention and identifying triggers can improve the quality of life for affected children and adults.
Area of Science:
- Gastroenterology
- Pediatrics
- Functional Gastrointestinal Disorders
Background:
- Cyclic vomiting syndrome (CVS) is a functional gastrointestinal disorder affecting children and adults.
- Recurrent vomiting episodes in CVS can significantly impair long-term quality of life, especially in pediatric patients.
Purpose of the Study:
- To emphasize the importance of careful patient assessment for suspected CVS.
- To highlight the necessity of accurate diagnosis using established criteria and excluding organic mimics.
- To outline optimal therapeutic strategies for symptom improvement and complication reduction in CVS.
Main Methods:
- Diagnosis based on established criteria for CVS.
- Exclusion of other organic diseases with similar symptoms.
- Implementation of optimal therapy for acute phases and long-term prophylaxis.
- Identification of potential triggering factors for vomiting episodes.
Main Results:
- Accurate diagnosis and exclusion of organic diseases are crucial for effective CVS management.
- Optimal therapy during prodromal and emetic phases can improve symptoms and reduce complications.
- Long-term prophylactic therapy and trigger identification aid in preventing vomiting episodes.
Conclusions:
- A systematic approach to CVS diagnosis and management is recommended.
- Improving clinical outcomes in CVS patients requires careful assessment, accurate diagnosis, and tailored therapeutic strategies.
- Early identification and management of triggers can significantly benefit patients with cyclic vomiting syndrome.
Related Concept Videos
01:22Pathophysiology of Vomiting
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through interaction...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:30Bulimia Nervosa
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...